Почетна › Hronična limfocitna leukemija › Kolorado › Aurora

Kliničke studije za Hronična limfocitna leukemija u gradu Aurora, CO

7 studija za Hronična limfocitna leukemija traži učesnike na lokacijama u gradu Aurora i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

Тражи се учесникФаза 3

Rocky Mountain Cancer Centers (Williams) Usor, Aurora

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06846671

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Тражи се учесникФаза 2

Rocky Mountain Cancer Center, Aurora

Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06588478

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле

Rocky Mountain Regional VA Medical Center, Aurora
UCHealth University of Colorado Hospital, Aurora

Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

Тражи се учесникФаза 1/2

Rocky Mountain Cancer Centers, Aurora

Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07520006

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Тражи се учесникФаза 3

Rocky Mountain Cancer Centers (Williams) Usor, Aurora

Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT06943872

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Тражи се учесникФаза 3

Rocky Mountain Cancer Centers (Williams) Usor, Aurora

Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07277231

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Тражи се учесникФаза 3

Rocky Mountain Cancer Centers - Aurora /ID# 267549, Aurora

Узраст 18 и старији · Оба пола · Ажурирано 9. 4. 2026. · NCT06428019

Studije za Hronična limfocitna leukemija u drugim gradovima

Ostale studije u gradu Aurora

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.